Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia

Dementia is a major cause of disability and dependency among older people. If the lives of people with dementia are to be improved, research and its translation into druggable target are crucial. Ancient systems of healthcare (Ayurveda, Siddha, Unani and Sowa-Rigpa) have been used from centuries for the treatment vascular diseases and dementia. This traditional knowledge can be transformed into novel targets through robust interplay of network pharmacology (NetP) with reverse pharmacology (RevP), without ignoring cutting edge biomedical data. This work demonstrates interaction between recent and traditional data, and aimed at selection of most promising targets for guiding wet lab validations. PROTEOME, DisGeNE, DISEASES and DrugBank databases were used for selection of genes associated with pathogenesis and treatment of vascular dementia (VaD). The selection of new potential drug targets was made by methods of NetP (DIAMOnD algorithm, enrichment analysis of KEGG pathways and biological processes of Gene Ontology) and manual expert analysis. The structures of 1976 phytomolecules from the 573 Indian medicinal plants traditionally used for the treatment of dementia and vascular diseases were used for computational estimation of their interactions with new predicted VaD-related drug targets by RevP approach based on PASS (Prediction of Activity Spectra for Substances) software. We found 147 known genes associated with vascular dementia based on the analysis of the databases with gene-disease associations. Six hundred novel targets were selected by NetP methods based on 147 gene associations. The analysis of the predicted interactions between 1976 phytomolecules and 600 NetP predicted targets leaded to the selection of 10 potential drug targets for the treatment of VaD. The translational value of these targets is discussed herewith. Twenty four drugs interacting with 10 selected targets were identified from DrugBank. These drugs have not been yet studied for the treatment of VaD and may be investigated in this field for their repositioning. The relation between inhibition of two selected targets (GSK-3, PTP1B) and the treatment of VaD was confirmed by the experimental studies on animals and reported separately in our recent publications.

[1]  M. Yenari,et al.  Hypothermia and pharmacological regimens that prevent overexpression and overactivity of the extracellular calcium-sensing receptor protect neurons against traumatic brain injury. , 2013, Journal of neurotrauma.

[2]  Shuangxing Hou,et al.  Association Between MTHFR Gene Polymorphisms, Smoking, and the Incidence of Vascular Dementia , 2013, Asia-Pacific journal of public health.

[3]  Tudor I. Oprea,et al.  ChemProt-3.0: a global chemical biology diseases mapping , 2016, Database J. Biol. Databases Curation.

[4]  M. McNutt,et al.  Expression and Distribution of Cystic Fibrosis Transmembrane Conductance Regulator in Neurons of the Human Brain , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[5]  E. Kerem,et al.  CFTR potentiator therapy ameliorates impaired insulin secretion in CF patients with a gating mutation. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  A. Lagunin,et al.  Attenuation of hyperhomocysteinemia induced vascular dementia by sodium orthovanadate perhaps via PTP1B: Pertinent downstream outcomes , 2019, Behavioural Brain Research.

[7]  N. Patel,et al.  Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3 , 2011, Indian journal of pharmacology.

[8]  Janos X. Binder,et al.  DISEASES: Text mining and data integration of disease–gene associations , 2014, bioRxiv.

[9]  I. Lizasoain,et al.  L-Kynurenine/Aryl Hydrocarbon Receptor Pathway Mediates Brain Damage After Experimental Stroke , 2014, Circulation.

[10]  Leonid Barski,et al.  The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED. , 2015, The American journal of emergency medicine.

[11]  M. Moro,et al.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia. , 2016, Current pharmaceutical design.

[12]  C. Williams,et al.  Prolactin is involved in glial responses following a focal injury to the juvenile rat brain , 2007, Neuroscience.

[13]  T. Bhardwaj,et al.  Protein Tyrosine Phosphatase 1B Inhibitors: A Molecular Level Legitimate Approach for the Management of Diabetes Mellitus , 2012, Medicinal research reviews.

[14]  J. Winslow,et al.  α2-Adrenoceptor antagonists potentiate acetylcholinesterase inhibitor effects on passive avoidance learning in the rat , 1996, Psychopharmacology.

[15]  L. McCullough,et al.  Inhibition of glycogen synthase kinase-3β enhances cognitive recovery after stroke: the role of TAK1 , 2015, Learning & memory.

[16]  F. Chapon,et al.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.

[17]  Alexey Lagunin,et al.  Glycogen synthase kinase-3 inhibition as a potential pharmacological target for vascular dementia: In silico and in vivo evidence , 2019, Comput. Biol. Medicine.

[18]  F. Colpaert,et al.  Effects of acute and subchronic administration of dexefaroxan, an alpha(2)-adrenoceptor antagonist, on memory performance in young adult and aged rodents. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[19]  Vladimir Poroikov,et al.  Multi-targeted natural products evaluation based on biological activity prediction with PASS. , 2010, Current pharmaceutical design.

[20]  James C. Hu,et al.  The Gene Ontology Resource: 20 years and still GOing strong , 2019 .

[21]  Mathias Dunkel,et al.  SuperPred: update on drug classification and target prediction , 2014, Nucleic Acids Res..

[22]  J. Kaur,et al.  Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms , 2016, Inflammopharmacology.

[23]  HOE-140, an antagonist of B2 receptor, protects against memory deficits and brain damage induced by moderate lateral fluid percussion injury in mice , 2014, Psychopharmacology.

[24]  F. Edwards,et al.  Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses , 2014, Hippocampus.

[25]  Andrew C. Terentis,et al.  Role of indoleamine 2,3-dioxygenase in health and disease. , 2015, Clinical science.

[26]  B. Wollnik,et al.  CADASIL syndrome in a large Turkish kindred caused by the R90C mutation in the Notch3 receptor , 2002, European journal of neurology.

[27]  Y. Geng,et al.  MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis. , 2014, Atherosclerosis.

[28]  A. Brossi,et al.  Synthesis and anticholinesterase activity of (-)-N1-norphysostigmine, (-)-eseramine, and other N(1)-substituted analogues of (-)-physostigmine. , 1988, Journal of Medicinal Chemistry.

[29]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[30]  A. Malaspina,et al.  Migraine with aura and white matter abnormalities: Notch3 mutation , 2000, Neurology.

[31]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Pal,et al.  Testosterone supplementation improves glucose homeostasis despite increasing hepatic insulin resistance in male mouse model of type 2 diabetes mellitus , 2016, Nutrition & Diabetes.

[33]  Chawnshang Chang,et al.  New Therapy via Targeting Androgen Receptor in Monocytes/Macrophages to Battle Atherosclerosis , 2014, Hypertension.

[34]  Quincy M. Samus,et al.  Dementia prevention, intervention, and care , 2017, The Lancet.

[35]  A. Carobrez,et al.  Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting α1- and β-adrenergic receptors. , 2013, Learning & memory.

[36]  I. Paul,et al.  Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test. , 1999, European journal of pharmacology.

[37]  Jun Wang,et al.  Insulin‐like growth factor‐1 secreted by brain microvascular endothelial cells attenuates neuron injury upon ischemia , 2013, The FEBS journal.

[38]  Vladimir Poroikov,et al.  Prediction of the Biological Activity Spectra of Organic Compounds Using the Pass Online Web Resource , 2014, Chemistry of Heterocyclic Compounds.

[39]  Vladimir Poroikov,et al.  PASS: prediction of activity spectra for biologically active substances , 2000, Bioinform..

[40]  Albert-László Barabási,et al.  A DIseAse MOdule Detection (DIAMOnD) Algorithm Derived from a Systematic Analysis of Connectivity Patterns of Disease Proteins in the Human Interactome , 2015, PLoS Comput. Biol..

[41]  Prabhat K. Singh,et al.  Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular dementia. , 2014, Current neurovascular research.

[42]  Lin He,et al.  DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactome , 2011, Nucleic Acids Res..

[43]  The Gene Ontology Consortium,et al.  The Gene Ontology Resource: 20 years and still GOing strong , 2018, Nucleic Acids Res..

[44]  Gary D Bader,et al.  Biological Network Exploration with Cytoscape 3 , 2014, Current protocols in bioinformatics.

[45]  Livia Perfetto,et al.  SIGNOR: a database of causal relationships between biological entities , 2015, Nucleic Acids Res..

[46]  R. Touyz,et al.  Testosterone Induces Vascular Smooth Muscle Cell Migration by NADPH Oxidase and c-Src–Dependent Pathways , 2012, Hypertension.

[47]  A. Artru,et al.  LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats. , 2002, Journal of neurotrauma.

[48]  J. Attems,et al.  Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain , 2012, Experimental Gerontology.

[49]  Rita Moretti,et al.  Rivastigmine in subcortical vascular dementia An open 22-month study , 2002, Journal of the Neurological Sciences.

[50]  Tudor I. Oprea,et al.  ChemProt-3.0: a global chemical biology diseases mapping , 2016, Database J. Biol. Databases Curation.

[51]  Vladimir Poroikov,et al.  Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors , 1999, J. Chem. Inf. Comput. Sci..

[52]  S. Cao,et al.  Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms , 2017, Oncotarget.

[53]  J. Sirviö,et al.  The effects of a specific alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and brain neurochemistry in aged Fisher 344 rats. , 2000, European journal of pharmacology.

[54]  Jörg Menche,et al.  Interactome-based approaches to human disease , 2017 .

[55]  K. Pattinson,et al.  The role of the nitric oxide pathway in brain injury and its treatment — From bench to bedside , 2015, Experimental Neurology.

[56]  Yung-Hsien Chang,et al.  Efficacy and Safety of a Chinese Herbal Medicine Formula (RCM-104) in the Management of Simple Obesity: A Randomized, Placebo-Controlled Clinical Trial , 2012, Evidence-based complementary and alternative medicine : eCAM.

[57]  K. Sunagawa,et al.  Telmisartan protects against cognitive decline via up-regulation of brain-derived neurotrophic factor/tropomyosin-related kinase B in hippocampus of hypertensive rats. , 2012, Journal of cardiology.

[58]  D. Ward,et al.  The vascular Ca2+-sensing receptor regulates blood vessel tone and blood pressure. , 2016, American journal of physiology. Cell physiology.

[59]  Vladimir Poroikov,et al.  Robustness of Biological Activity Spectra Predicting by Computer Program PASS for Noncongeneric Sets of Chemical Compounds , 2000, J. Chem. Inf. Comput. Sci..

[60]  T. Toung,et al.  Age-Dependent Effects of Testosterone in Experimental Stroke , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[62]  A. Abdel-Zaher,et al.  The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists. , 2001, Pharmacological research.

[63]  S. Yeh,et al.  Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells , 2013, Nuclear receptor signaling.

[64]  C. Maggi,et al.  Antagonism of Bradykinin B2 Receptor Prevents Inflammatory Responses in Human Endothelial Cells by Quenching the NF-kB Pathway Activation , 2014, PloS one.

[65]  F. Jourdan,et al.  Noradrenergic control of odor recognition in a nonassociative olfactory learning task in the mouse. , 2007, Learning & memory (Cold Spring Harbor, N.Y.).

[66]  S. Bandyopadhyay,et al.  Diverse roles of extracellular calcium‐sensing receptor in the central nervous system , 2010, Journal of neuroscience research.

[67]  Jun-Hyun Yoo,et al.  Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[68]  L. Eroǧlu,et al.  L-NAME prevents anxiety-like and depression-like behavior in rats exposed to restraint stress. , 2006, Methods and findings in experimental and clinical pharmacology.

[69]  J. Borén,et al.  The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  Olivier Michielin,et al.  SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules , 2019, Nucleic Acids Res..

[71]  M. Dichgans,et al.  Prolonged Cerebral Transit Time in CADASIL: A Transcranial Ultrasound Study , 2002, Stroke.

[72]  R. Eid,et al.  Effect of dehydroepiandrosterone (DHEA) on memory and brain derived neurotrophic factor (BDNF) in a rat model of vascular dementia. , 2014, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[73]  A. Eichmann,et al.  PTP1b Is a Physiologic Regulator of Vascular Endothelial Growth Factor Signaling in Endothelial Cells , 2014, Circulation.

[74]  X. Zong,et al.  Activation of GABAB Receptors Ameliorates Cognitive Impairment via Restoring the Balance of HCN1/HCN2 Surface Expression in the Hippocampal CA1 Area in Rats With Chronic Cerebral Hypoperfusion , 2014, Molecular Neurobiology.

[75]  G. Werstuck,et al.  Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice. , 2014, The American journal of pathology.

[76]  R. Franco,et al.  Mechanisms of cannabidiol neuroprotection in hypoxic–ischemic newborn pigs: Role of 5HT1A and CB2 receptors , 2013, Neuropharmacology.

[77]  Yea-Ru Yang,et al.  The Neuroprotective Effects of Intramuscular Insulin-Like Growth Factor-I Treatment in Brain Ischemic Rats , 2013, PloS one.

[78]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[79]  M. Mogi,et al.  Direct angiotensin II type 2 receptor stimulation by compound 21 prevents vascular dementia. , 2015, Journal of the American Society of Hypertension : JASH.

[80]  C. de Montigny,et al.  Effects of long-term treatment with the α2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[81]  Y. Ichimaru,et al.  Possible participation of extracellular calcium-sensing receptor in blood pressure regulation in rats , 2011, Brain Research.

[82]  Xiang Zhou,et al.  The 981C>T polymorphism in protein tyrosine phosphatase 1B is associated with decreased risk of coronary artery disease in Chinese Han population. , 2011, Atherosclerosis.

[83]  D. Clemmons,et al.  Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer , 2007, Nature Reviews Drug Discovery.

[84]  Vladimir V Poroikov,et al.  Chemo- and bioinformatics resources for in silico drug discovery from medicinal plants beyond their traditional use: a critical review. , 2014, Natural product reports.

[85]  Jacob Raber,et al.  AR, apoE, and cognitive function , 2008, Hormones and Behavior.

[86]  Guang Chen,et al.  In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3 , 2004, Neuropsychopharmacology.

[87]  Jian Cheng,et al.  Dose-Dependent Effects of Androgens on Outcome after Focal Cerebral Ischemia in Adult Male Mice , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[88]  B. Leavitt,et al.  The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain , 2013, Experimental Neurology.

[89]  Evi X. Stavrou,et al.  Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation. , 2013, Blood.

[90]  Shile Huang,et al.  Role of PTP-1B in aortic smooth muscle cell motility and tyrosine phosphorylation of focal adhesion proteins. , 1999, American journal of physiology. Heart and circulatory physiology.

[91]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[92]  Núria Queralt-Rosinach,et al.  DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..

[93]  A. Kashiwagi,et al.  New α2-Adrenergic Blocker (DG-5128) Improves Insulin Secretion and In Vivo Glucose Disposal in NIDDM Patients , 1986, Diabetes.

[94]  P. Delafontaine,et al.  Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging. , 2014, Frontiers of hormone research.

[95]  A. Malandrini,et al.  Asymptomatic cores and paracrystalline mitochondrial inclusions in CADASIL , 2002, Neurology.

[96]  David S. Wishart,et al.  DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..

[97]  Andrey Rzhetsky,et al.  DiseaseConnect: a comprehensive web server for mechanism-based disease–disease connections , 2014, Nucleic Acids Res..

[98]  B. Palmier,et al.  LF 16‐0687 Ms, a bradykinin B2 receptor antagonist, reduces ischemic brain injury in a murine model of transient focal cerebral ischemia , 2003, British journal of pharmacology.

[99]  T. England,et al.  Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors , 2015, British journal of pharmacology.

[100]  P. Delafontaine,et al.  Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E–Deficient Mice , 2016, Circulation.

[101]  Y. Okada,et al.  Protective Role of Cardiac CFTR Activation Upon Early Reperfusion Against Myocardial Infarction , 2012, Cellular Physiology and Biochemistry.

[102]  M. Viitanen,et al.  CADASIL and CARASIL , 2014, Brain pathology.

[103]  C. Brayne,et al.  Microglial immunophenotype in dementia with Alzheimer’s pathology , 2016, Journal of Neuroinflammation.

[104]  Bo Zhang,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application: Traditional Chinese medicine network pharmacology: theory, methodology and application , 2014 .

[105]  Gelin Xu,et al.  Down-regulation of IGF-1/IGF-1R in hippocampus of rats with vascular dementia , 2012, Neuroscience Letters.

[106]  A. Brambrink,et al.  Effects of Androgens on Early Post-ischemic Neurogenesis in Mice , 2013, Translational Stroke Research.

[107]  N. Greig,et al.  Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines. , 2002, Journal of medicinal chemistry.

[108]  S. Han,et al.  Insulin‐like growth factor‐1 receptor polymorphism and ischemic stroke: a case–control study in Chinese population , 2008, Acta neurologica Scandinavica.

[109]  Thomas A. Halgren,et al.  Identifying and Characterizing Binding Sites and Assessing Druggability , 2009, J. Chem. Inf. Model..

[110]  J. Orgogozo,et al.  COL4A1 mutation in Axenfeld–Rieger anomaly with leukoencephalopathy and stroke , 2007, Annals of neurology.

[111]  E. J. Belin de Chantemèle,et al.  Deletion of protein tyrosine phosphatase 1b in proopiomelanocortin neurons reduces neurogenic control of blood pressure and protects mice from leptin- and sympatho-mediated hypertension. , 2015, Pharmacological research.

[112]  F. Colpaert,et al.  Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. , 1999, The Journal of pharmacology and experimental therapeutics.

[113]  Jesús Avila,et al.  Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors , 2010, Expert review of neurotherapeutics.

[114]  M. Mitcheva,et al.  Selective Nitric Oxide Synthase Inhibitor 7-Nitroindazole Protects against Cocaine-Induced Oxidative Stress in Rat Brain , 2015, Oxidative medicine and cellular longevity.

[115]  C. Patterson,et al.  Moderately Elevated Plasma Homocysteine, Methylenetetrahydrofolate Reductase Genotype, and Risk for Stroke, Vascular Dementia, and Alzheimer Disease in Northern Ireland , 2002, Stroke.

[116]  C. Pike,et al.  Protective actions of sex steroid hormones in Alzheimer’s disease , 2009, Frontiers in Neuroendocrinology.

[117]  E. Inscho,et al.  Protein tyrosine phosphatase 1B (PTP1B): a major regulator of leptin‐mediated control of cardiovascular function , 2009, Circulation.

[118]  Aiping Lu,et al.  Traditional Chinese Medicine-Based Network Pharmacology Could Lead to New Multicompound Drug Discovery , 2012, Evidence-based complementary and alternative medicine : eCAM.

[119]  John P. Overington,et al.  The Molecular Basis of Predicting Druggability , 2008 .

[120]  Yanli Wang,et al.  PubChem BioAssay: 2017 update , 2016, Nucleic Acids Res..

[121]  B. Saletu,et al.  Safety of Nicergoline as an Agent for Management of Cognitive Function Disorders , 2014, BioMed research international.

[122]  S. Soper,et al.  Expression profile based gene clusters for ischemic stroke detection. , 2014, Genomics.

[123]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[124]  Shao Li,et al.  Traditional Chinese medicine network pharmacology: theory, methodology and application. , 2013, Chinese journal of natural medicines.

[125]  Jialing Liu,et al.  Calcium-sensing receptor (CaSR) as a novel target for ischemic neuroprotection , 2014, Annals of clinical and translational neurology.

[126]  B. Wicksteed,et al.  Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male. , 2016, Cell metabolism.

[127]  Xue Xu,et al.  Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. , 2013, Journal of ethnopharmacology.

[128]  K A Murtazalieva,et al.  How good are publicly available web services that predict bioactivity profiles for drug repurposing?$ , 2017, SAR and QSAR in environmental research.

[129]  Takahiro Matsumoto,et al.  Androgen Receptor Promotes Sex-Independent Angiogenesis in Response to Ischemia and Is Required for Activation of Vascular Endothelial Growth Factor Receptor Signaling , 2013, Circulation.

[130]  Gangchun Wang,et al.  Regulation of glycogen synthase kinase-3 during bipolar mania treatment. , 2010, Bipolar disorders.

[131]  M. Hsiao,et al.  Involvement of two distinct signalling pathways in IGF‐1‐mediated central control of hypotensive effects in normotensive and hypertensive rats , 2014, Acta physiologica.

[132]  M. Dichgans,et al.  NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL , 2001, Neurology.

[133]  Lirong Wang,et al.  TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database , 2013, The AAPS Journal.

[134]  M. Scheinin,et al.  α2-adrenoceptor regulation of blood glucose homeostasis. , 2011, Basic & clinical pharmacology & toxicology.

[135]  Peng Jiang,et al.  Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..

[136]  M. Zarrindast,et al.  Hippocampal α-adrenoceptors involve in the effect of histamine on spatial learning , 2014, Physiology and Behavior.

[137]  Changlian Zhu,et al.  Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia , 2002, Stroke.

[138]  J. Trojanowski,et al.  Vascular disease and dementias: Paradigm shifts to drive research in new directions , 2013, Alzheimer's & Dementia.

[139]  A. Lagunin,et al.  Vascular dementia: Molecular targets of neuroprotective therapy , 2017, Biology Bulletin Reviews.